Skip to main content
. 2021 Jun 1;37(6):409–420. doi: 10.1089/aid.2021.0028

FIG. 4.

FIG. 4.

Stage 1, scab, slight erythema; stage 2, slight swelling at dose site, scab, slight edema; stage 3, mild-to-moderate edema, scab, swelling, ocular discharge, emesis; stage 4, macroscopic descriptions of swelling and/or firmness in the interscapular implant sites, no expressible fluid; stage 5, slight swelling, emesis, red-tinged material at dose site and yellow discharge; mild edema, mild erythema.